Paper Details

Paper Title

An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas.

Paper Journal Title

Ann Oncol

Paper Citation Count

279

Paper Publication Year

2013

Bio Mention

Mesh Descriptor

Column Actions